Truist Financial Corp. closed 8.08% short of its 52-week high of $49.06, which the company achieved on November 25th.

In the last three months, 20 analysts have published ratings on Exelixis EXEL, offering a diverse range of perspectives from bullish to bearish. The table below summarizes their recent ratings, ...

View the latest Truist Financial Corp. (TFC) stock price, news, historical charts, analyst ratings and financial information from WSJ.

The 12-month price targets, analyzed by analysts, offer insights with an average target of $249.58, a high estimate of $305.00, and a low estimate of $212.00. Observing a 4.51% increase, the current ...

Detailed price information for Gxo Logistics Inc (GXO-N) from The Globe and Mail including charting and trades.

Mastercard Incorporated (NYSE:MA) secures a place on our list of the 12 Best Ethical Companies to Invest in 2025. Ahead of ...

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, ...

Genmab A/S (NASDAQ:GMAB) is one of the best biotech stocks to buy according to billionaire Steve Cohen. On July 8, Truist ...

Shares of Truist Financial Corp. TFC advanced 1.35% to $45.82 Wednesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 0.78% to 6,358 ...

Gain insights into Exelixis' Q2 2025 performance: 19% cabozantinib revenue growth, NET market leadership, and strategic advancements.

Graham announced an upgrade to the full year adjusted EBITDA guidance: "Full year adjusted EBITDA is now expected to be in the range of $705 million to $725 million based on current FX rates. We ...